RNA News and Press, Avidity Biosciences Inc. From 01/29/26

2026-01-29 22:30:00 ET The following segment was excerpted from the Harbor Small Cap Growth Fund ( HASGX ) Q4 2025 Commentary. ... Read the full article on Seeking Alpha For further details see: Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance

2026-01-16 14:18:10 ET More on healthcare stocks XLV Vs. BME: Total Return Or Income, Which Healthcare Strategy Wins? IYH: Elevated Valuations And Slowing Growth Signal Subpar 2026 Returns Baxter International Inc. (BAX) Presents at 44th Annual J.P. Morgan Healthcare...

2026-01-07 16:15:00 ET Discoveries made by companies in the genetics sector help support every other life science industry in a variety of ways. One of the genetic sector's major contributions is the discovery of new genetic drivers of diseases. Genetic testing has grown substantial...

2026-01-02 06:52:42 ET The State Street® SPDR® S&P® Biotech ETF ( XBI ) is up approximately 65% from its April 9th lows following the aftermath of the sharp but short decline in the overall markets following the announcement of ' reciprocal tariffs ' by the ad...

2025-12-17 12:29:56 ET Fast Facts About the Direxion Daily S&P Biotech Bull 3X ETF Read the full article on Seeking Alpha For further details see: LABU: The Risks And Rewards Of A Leveraged Biotechnology ETF

2025-12-10 13:43:43 ET More on Dyne Therapeutics, Avidity Biosciences Dyne Therapeutics: Why The $350M Public Offering Was Critical Dyne Therapeutics, Inc. (DYN) Discusses Positive Topline Results From DELIVER Registrational Expansion Cohort in Duchenne Muscular Dystrophy Tr...

2025-12-03 18:22:57 ET The biotech sector got off to an inauspicious start to December in trading on Monday. The iShares Biotechnology ETF ( IBB ) was off 2.14% yesterday while the State Street® SPDR® S&P® Biotech ETF ( XBI ) dropped 2.69% on Monday. This ...

Halper Sadeh LLC Encourages RNA, TCBX, ATXS, FSUN Shareholders to Contact the Firm to Discuss Their Rights PR Newswire Shareholders should contact the firm immediately as there may be limited time to enforce your rights.   NEW YORK , Dec. 1, 2025 /PRNewswire/ -- Hal...

Avidity Biosciences Announces U.S. Managed Access Program (MAP) for Investigational Therapy del-zota in DMD44 PR Newswire SAN DIEGO , Nov. 19, 2025 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA ...

2025-11-18 11:25:00 ET More on markets UBS shrugs off high valuations as it focuses on strong earnings Cantor Fitzgerald says current de-risking clears a runway for a year-end rally 2 Events Could Make Me Buy More Than Ever Commodities And The Next Major Macr...